Physician profile
Gary Allen
NPI 1063467256
$49,905.17
in general payments reported to CMS, 2019-2025
22 companies · $391 in 2025
The $391 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $958 · 2020: $811 · 2021: $11K · 2022: $31K · 2023: $5,848 · 2024: $102 · 2025: $391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,167 · Food and Beverage: $1,122 · Travel and Lodging: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,166.67 |
| Food and Beverage | $1,122.18 |
| Travel and Lodging | $1,052.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $44,587.24 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $1,852.86 | 2019-2023 | |
| Medtronic, INC. | $1,585.07 | 2023-2024 | Turbohawk, Hawkone |
| Inari Medical, INC. | $644.56 | 2019-2021 | |
| Abiomed | $263.02 | 2019-2021 | |
| Abbott Laboratories | $252.13 | 2019-2025 | Esprit, Mitraclip, Supera |
| Cardiovascular Systems INC. | $152.54 | 2019-2022 | |
| Ekos Corporation | $89.72 | 2019 | |
| Terumo Medical Corporation | $71.23 | 2023-2025 | Glidewire, Tr Band, Metacross Otw |
| Solventum Corporation | $65.02 | 2025 | 3m Tegaderm |
| Vertos Medical, INC. | $57.25 | 2021 | |
| Elutia, INC. | $38.28 | 2021-2023 | |
| Pfizer INC. | $37.78 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.45 | 2019-2021 | |
| Cordis US Corp. | $31.96 | 2023 | Saber, Mynx Control |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27.24 | 2021 | |
| Amgen INC. | $22.20 | 2021 | |
| Flowonix Medical Incorporated | $20.17 | 2019 | |
| Asahi Intecc USA, INC. | $19.41 | 2022 | |
| Bard Peripheral Vascular, INC. | $19.08 | 2025 | Rotarexs 6 F X 135 Cm |
| Tactile Systems Technology INC | $16.16 | 2025 | Flexitouch Plus, Nimbl |
| Getinge USA Sales, LLC | $14.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.